Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Development Institute of Korean Medicine (NIKOM) is a specialized public institution under the South Korean Ministry of Health and Welfare dedicated to the advancement and globalization of Traditional Korean Medicine (TKM). NIKOM focuses on the standardization of herbal materials, the development of new TKM-based drugs, and the modernization of clinical practices through rigorous scientific validation. The institute operates high-tech R&D centers and GMP-certified manufacturing facilities to support the entire lifecycle of Korean medicine products, from raw material cultivation to clinical trial material production. By fostering industrial growth and international cooperation, NIKOM aims to integrate traditional wisdom with modern biotechnology to improve public health outcomes. It serves as a critical bridge for private companies seeking to commercialize standardized herbal therapies and evidence-based traditional treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Development Institute of Korean Medicine.